The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information Pack. Post Hearing Information Pack of Distinct Healthcare Holdings Limited 卓正醫療控股有限公司 (the "Company") (A company inco ...

Investment Overview - INVL Private Equity Fund II, the largest private equity fund in the Baltics, has partnered with the International Finance Corporation (IFC) and Accession Capital Partners (ACP) to invest in POLMED, a leading private healthcare provider in Poland [1] - The investment aims to provide expansion capital for POLMED to acquire KN Group, a prominent oncology center, marking one of the first acquisitions for INVL Private Equity Fund II [1] Company Profile: POLMED - Founded in 1999, POLMED has become one of Poland's leading private healthcare groups, generating revenues exceeding EUR 100 million in 2024 [2][10] - The company operates a network of 38 facilities and employs around 2,000 staff, serving over 4 million patients annually and collaborating with more than 4,000 medical partners [2][10] Acquisition Details - The target for acquisition, KN Group, includes Radomskie Centrum Onkologii, Gamma Knife Centre, and Radom Family Centre, which collectively operate three facilities and employ over 700 people [3] - KN Group is recognized for its high-quality oncology services and is led by renowned neurosurgeons who will continue their roles post-acquisition [3] Strategic Implications - The acquisition is subject to regulatory approval from the Polish Office of Competition and Consumer Protection [4] - POLMED's leadership will remain intact, with the founder and president, Radosław Szubert, and co-founder, Romuald Magdoń, retaining majority ownership [4] - The partnership is expected to enhance POLMED's service offerings and improve patient comfort during diagnostics and therapy [5] Investor Insights - The investment consortium believes that with the right support, POLMED can achieve significant growth and become a national leader in healthcare [6] - IFC aims to assist POLMED in transforming into a digitally enabled healthcare platform, expanding access to quality care in Poland [6] About INVL Private Equity Fund II - The fund aims to build a diversified portfolio by acquiring significant stakes in high-growth companies, with investments ranging from EUR 10 million to EUR 60 million [8] - Managed by INVL Asset Management, the fund focuses on opportunities in the Baltic countries, Poland, Romania, and the broader European Union [8] About Accession Capital Partners (ACP) - ACP has been active in Central Europe since 2000 and has raised over EUR 1.2 billion across five dedicated growth capital funds [12] - The firm is backed by reputable institutional investors, including the European Investment Fund and the International Finance Corporation [12]